Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma.
Saved in:
| Title: | Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma. |
|---|---|
| Authors: | Papathanasiou T; Clinical Pharmacology, Modeling and Simulation, GSK, Baar, Switzerland. theo.x.papathanasiou@gsk.com., Kaullen J; Certara, Radnor, PA, USA., Polireddy K; Certara, Radnor, PA, USA., Chen X; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA., Ho YL; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA., Taylor A; Certara, Radnor, PA, USA., Struemper H; Clinical Pharmacology, Modeling and Simulation, GSK, Durham, NC, USA., Carreño F; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA., Ferron-Brady G; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA. |
| Source: | Clinical pharmacokinetics [Clin Pharmacokinet] 2025 Jun; Vol. 64 (6), pp. 925-942. Date of Electronic Publication: 2025 May 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40447948 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Papathanasiou+T%22">Papathanasiou T</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Baar, Switzerland. theo.x.papathanasiou@gsk.com.<br /><searchLink fieldCode="AU" term="%22Kaullen+J%22">Kaullen J</searchLink>; Certara, Radnor, PA, USA.<br /><searchLink fieldCode="AU" term="%22Polireddy+K%22">Polireddy K</searchLink>; Certara, Radnor, PA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ho+YL%22">Ho YL</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Taylor+A%22">Taylor A</searchLink>; Certara, Radnor, PA, USA.<br /><searchLink fieldCode="AU" term="%22Struemper+H%22">Struemper H</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Carreño+F%22">Carreño F</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ferron-Brady+G%22">Ferron-Brady G</searchLink>; Clinical Pharmacology, Modeling and Simulation, GSK, Collegeville, PA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227606849%22">Clinical pharmacokinetics</searchLink> [Clin Pharmacokinet] 2025 Jun; Vol. 64 (6), pp. 925-942. <i>Date of Electronic Publication: </i>2025 May 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+part+of+Springer+Science%2BBusiness+Media%22">Adis, part of Springer Science+Business Media </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>7606849 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1926 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203125963%22">03125963 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacokinet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40447948 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40262-025-01508-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 925 Titles: – TitleFull: Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Papathanasiou T – PersonEntity: Name: NameFull: Kaullen J – PersonEntity: Name: NameFull: Polireddy K – PersonEntity: Name: NameFull: Chen X – PersonEntity: Name: NameFull: Ho YL – PersonEntity: Name: NameFull: Taylor A – PersonEntity: Name: NameFull: Struemper H – PersonEntity: Name: NameFull: Carreño F – PersonEntity: Name: NameFull: Ferron-Brady G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2025 Jun Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1179-1926 Numbering: – Type: volume Value: 64 – Type: issue Value: 6 Titles: – TitleFull: Clinical pharmacokinetics Type: main |
| ResultId | 1 |